The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Transcriptional Activation by Tetracyclines in Mammalian Cells
Abstract
A transcriptional transactivator was developed that fuses the VP16 activation domain with a mutant Tet repressor from Escherichia coli. This transactivator requires certain tetracycline (Tc) derivatives for specific DNA binding. Thus, addition of doxycycline to HeLa cells that constitutively synthesized the transactivator and that contained an appropriate, stably integrated reporter unit rapidly induced gene expression more than a thousandfold. The specificity of the Tet repressor-operator-effector interaction and the pharmacological characteristics of Tc's make this regulatory system well suited for the control of gene activities in vivo, such as in transgenic animals and possibly in gene therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 1995, Gossen et al. developed the Tet-On system (Fig. 1C), a regulatory system that allows activation of gene expression by the addition - instead of removal - of dox [12].”
From Tet-On Systems For Doxycycline-inducible Gene Expression (2016) · cites this paper as [12]
In the citing paper
“This reverse-TetR (rTetR) differed at four amino acid positions from the original protein (Fig. 2).”
From Tet-On Systems For Doxycycline-inducible Gene Expression (2016) · cites this paper as [12]
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Self-citation
Flagged first, then by citations
Research works printed but not linked: 13
- 10.1016/0003-2697(87)90021-2 · DOI
- 10.1016/0003-2697(83)90418-9 · DOI
- FURTH, P.A., TEMPORAL CONTROL OF GENE-EXPRESSION IN TRANSGENIC MICE BY A TETRACYCLINE-RESPONSIVE PROMOTER, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 91: 9302 (1994).
- GOSSEN, M, CONTROL OF GENE ACTIVITY IN HIGHER EUKARYOTIC CELLS BY PROKARYOTIC REGULATORY ELEMENTS, TRENDS IN BIOCHEMICAL SCIENCES 18: 471 (1993). · DOI
- HECHT, B, NONINDUCIBLE TET REPRESSOR MUTATIONS MAP FROM THE OPERATOR BINDING MOTIF TO THE C-TERMINUS, JOURNAL OF BACTERIOLOGY 175: 1206 (1993). · DOI
- HILLEN, W, MECHANISMS UNDERLYING EXPRESSION OF TN10 ENCODED TETRACYCLINE RESISTANCE, ANNUAL REVIEW OF MICROBIOLOGY 48: 345 (1994). · DOI · Paper page
- HINRICHS, W, STRUCTURE OF THE TET REPRESSOR TETRACYCLINE COMPLEX AND REGULATION OF ANTIBIOTIC-RESISTANCE, SCIENCE 264: 418 (1994). · DOI · Paper page
- MULLER G THESIS U ERLANGEN NU (1995).
- RESNITZKY, D, ACCELERATION OF THE G(1)/S PHASE-TRANSITION BY EXPRESSION OF CYCLIN-D1 AND CYCLIN-E WITH AN INDUCIBLE SYSTEM, MOLECULAR AND CELLULAR BIOLOGY 14: 1669 (1994).
- 10.1073/pnas.81.7.1991 · DOI
- SOUTHERN, P.J., J MOL APPL GENET 1: 327 (1982).
- WEINMANN, P, A CHIMERIC TRANSACTIVATOR ALLOWS TETRACYCLINE-RESPONSIVE GENE-EXPRESSION IN WHOLE PLANTS, PLANT JOURNAL 5: 559 (1994). · DOI
- YARRANTON, G.T., CURR OPIN BIOTECH 3: 506 (1992). · DOI
Cited by
Sorted by citations
Items 801–900 of 1,006
Bcl-XL down-regulation suppresses the tumorigenic potential of NPM/ALK in vitro and in vivo.
Coluccia, A., Perego, S., Cleris, L., Gunby, R., Passoni, L., Marchesi, E., Formelli, F., & Gambacorti-Passerini, C. (2004) · Blood · doi:10.1182/blood-2003-09-3144 · Cited by 43
Schmidt, M. H. H., Broll, R., Bruch, H., Bogler, O., & Duchrow, M. (2003) · Journal of Pathology · doi:10.1002/path.1221 · Cited by 43
Lindeberg, J., Mattsson, R., & Ebendal, T. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10213 · Cited by 43
“It cannot bind the operon until tetracycline is added, so addition of the antibiotic will induce transcription of the tetO-controlled gene instead of silencing it (Gossen et al., 1995; Kistner et al., 1996).”
BackgroundJiang, D., Jha, N., Boonplueang, R., & Andersen, J. K. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00151.x · Cited by 43
“To circumvent this, we have expressed catalase in PC12 under the control of the inducible reverse tetracycline system to allow its expression to be upregulated only upon addition of a lipid-soluble derivative of tetracycline, doxycyclin (dox, Gossen et al. 1995).”
MethodChapter 1 Genetic Dissection of Neural Circuits and Behavior in Mus musculus
Havekes, R., & Abel, T. G. (2009) · Advances in genetics · doi:10.1016/s0065-2660(09)65001-x · Cited by 36
“To this end, the laboratory of Hermann Bujard developed a promoter based on the regulatory elements of the tetracycline resistance operon of E. coli (Furth et al., 1994; Gossen et al., 1994, 1995).”
MethodGoldring, C. E., Kitteringham, N. R., Jenkins, R. E., Lovatt, C. A., Randle, L. E., Abdullah, A., Owen, A., Liu, X., Butler, P. J., Williams, D. P., et al. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00133.2005 · Cited by 38
“, reverse tTA (rtTA), is used, whereby amino acid substitutions in the tTA protein yield a transcriptional activator in the presence of dox (17, 20, 32).”
Self-citationChtarto, A., Humbert-Claude, M., Bockstael, O., Das, A. T., Boutry, S., Breger, L. S., Klaver, B., Melas, C., Barroso-Chinea, P., Gonzalez-Hernandez, T., et al. (2016) · Molecular Therapy - Methods & Clinical Development · doi:10.1038/mtm.2016.27 · Cited by 43
Ishii, T., Miyazawa, M., Onodera, A., Yasuda, K., Kawabe, N., Kirinashizawa, M., Yoshimura, S., Maruyama, N., Hartman, P. S., & Ishii, N. (2011) · Mitochondrion · doi:10.1016/j.mito.2010.09.006 · Cited by 42
“The original system was modified using the reverse Tccontrolled transactivator (rtTA) (Gossen et al., 1995) and the Tccontrolled transcriptional silencer (tTS) with the improved Kruppelassociated box (KRAB) domain of human Kox-1 (Freundlieb et al., 1999; Uchida et al., 2006) that also included a…”
MethodSingle-molecule states link transcription factor binding to gene expression
Doughty, B. R., Hinks, M. M., Schaepe, J. M., Marinov, G. K., Thurm, A. R., Rios-Martinez, C., Parks, B. E., Tan, Y., Marklund, E., Dubocanin, D., et al. (2024) · Nature · doi:10.1038/s41586-024-08219-w · Cited by 42
“We integrated these constructs at the AAVS1 safe-harbour locus in K562 cells constitutively expressing the synthetic TF rTetR–VP48, which binds to TetO following doxycycline (dox) addition 19 (Fig.”
Control of mammalian gene expression by modulation of polyA signal cleavage at 5′ UTR
Luo, L., Jea, J. D.-Y., Wang, Y., Chao, P.-W., & Yen, L. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01989-0 · Cited by 50
“The commonly used tet-on system is a powerful gene regulation tool in biological studies 5 , but its use of foreign regulatory ‘transactivator’ protein can trigger immune responses in nonhuman primates 6–8 .”
Brauer, E., Lange, T., Keller, D., Görlitz, S., Cho, S., Keye, J., Gossen, M., Petersen, A., & Kornak, U. (2022) · Aging Cell · doi:10.1111/acel.13744 · Cited by 50
“We either treated cells with the DNA crosslinking agent Mitomycin C (MMC) or established a cell cycle arrest through tetracycline- inducible expression of p16 or p21 mediated by the tet- transactivator, rtTA (Figure 1a, Figure S1a) (Gossen et al., 1995; Heinz et al., 2011).”
MethodSelf-citationPERSIST platform provides programmable RNA regulation using CRISPR endoRNases
DiAndreth, B., Wauford, N., Hu, E., Palacios, S., & Weiss, R. (2022) · Nature Communications · doi:10.1038/s41467-022-30172-3 · Cited by 55
Chen, X., Li, T., Wang, X., Du, Z., Liu, R., & Yang, Y. A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1343 · Cited by 44
“doxycycline, Dox), by either activating (Tet-On) or inactivating gene expression (Tet-Off) (17,39).”
BackgroundHoyng, S., Gnavi, S., Winter, F. D., Eggers, R., Ozawa, T., Zaldumbide, A., Hoeben, R., Malessy, M., & Verhaagen, J. (2014) · Gene Therapy · doi:10.1038/gt.2014.22 · Cited by 42
Fine tuning the LightOn light-switchable transgene expression system.
Ma, Z., Du, Z., Chen, X.-J., Wang, X., & Yang, Y. (2013) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2013.09.092 · Cited by 42
Malphettes, L., Weber, C. C., Elbaba, M., Schoenmakers, R., Aubel, D., Weber, W., & Fussenegger, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni107 · Cited by 42
“Following the generic design principle of the TET system, a wide variety of bacterial response regulators have been adapted for use as mammalian gene regulation systems, including those responsive to (i) tetracycline derivatives (7,8), (ii) streptogramin (9), (iii) macrolide (10) and (iv) coumermycin (11) antibiotics,…”
BackgroundInfluentialUeberham, U., Ueberham, E., Brückner, M., Seeger, G., Gärtner, U., Gruschka, H., Gebhardt, R., & Arendt, T. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04189.x · Cited by 42
Characterization of tetracycline-inducible bitransgenic Krt12rtTA/+/tet-O-LacZ mice.
Chikama, T., Hayashi, Y., Liu, C.-Y., Terai, N., Terai, K., Kao, C., Wang, L., Hayashi, M., Nishida, T., Sanford, P., et al. (2005) · Investigative Ophthalmology and Visual Science · doi:10.1167/iovs.04-1464 · Cited by 42
Straub, J. A., Lipscomb, E. A., Yoshida, E. S., & Freeman, R. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01688.x · Cited by 42
“These cells stably express a reversetetracycline transactivator that in the presence of inducer (tetracycline or doxycycline) binds to tetracycline response elements in the promoters of target genes, driving their expression (Gossen et al. 1995).”
BackgroundGenetically engineered mice for studies of stress-related clinical conditions
Müller, M. B., & Keck, M. E. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00049-8 · Cited by 38
Characteristics of adenovirus-mediated tetracycline-controllable expression system.
Mizuguchi, H., & Hayakawa, T. (2001) · Biochimica et Biophysica Acta · doi:10.1016/s0304-4165(01)00195-7 · Cited by 42
Changing colors in mice: an inducible system that delivers.Preprint
Mills, A. (2001) · Genes & Development · doi:10.1101/gad.909301 · Cited by 42
“This chimeric protein consists of a fusion between the herpes simplex virus transactivating domain VP16 and the tetracycline repressor from E. coli (Gossen and Bujard 1992; Gossen 1995). tTA binds to the tet operator (tetO) when tet is absent.”
BackgroundManickan, E., Satoi, J., Wang, T. C., & Liang, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009770200 · Cited by 42
Roh, M., Paterson, A. J., Asa, S. L., Chin, E., & Kudlow, J. E. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.4.0625 · Cited by 47
Timing is everything in life: conditional transgene expression in the cardiovascular system.
Fishman, G. I. (1998) · Circulation Research · doi:10.1161/01.res.82.8.837 · Cited by 42
Inducible Transgene Expression in Mouse Stem Cells
Ting, D. T., Kyba, M., & Daley, G. Q. (2004) · Humana Press eBooks · doi:10.1385/1-59259-826-9:023 · Cited by 37
“The same group later created a VP16 fusion with a mutated TetR that bound TetO in the presence of doxycycline, which stimulated expression of a target gene (44).”
BackgroundMethodProduction of functional transgenic mice by DNA pronuclear microinjection.
Auerbach, A. B. (2004) · Acta Biochimica Polonica · doi:10.18388/abp.2004_3593 · Cited by 45
“The second transgenic line — activator is expressing DNA-binding domain of tet-represor (tetR) fussed to transactivator domain from herpes simplex virus (Gossen et al., 1995).”
BackgroundA regulatory system for target gene expression.
Mm, B., Bw, O., & Sy, T. (1998) · Frontiers in bioscience · doi:10.2741/a258 · Cited by 42
“Tetracyclin based regulatory systems The tetracyclin (tet)-inducible system comprises of the tet transactivator protein (tTA), a chimeric protein containing the VP16 activation domain fused to the tet repressor of Escherichia coli (12).”
BackgroundMolecular switches in animal cells
Hörner, M., & Weber, W. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.032 · Cited by 38
Making Better Transgenic Models: Conditional, Temporal, and Spatial Approaches
Ristevski, S. (2005) · Molecular Biotechnology · doi:10.1385/mb:29:2:153 · Cited by 61
In Vitro and In Vivo Secretion of Cloned Antibodies by Genetically Modified Myogenic Cells
Noël, D., Pelegrin, M., Marin, M., Biard-Piechaczyk, M., Ourlin, J., Mani, J., & Piechaczyk, M. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.10-1219 · Cited by 41
“…and other non-B cells usable in gene therapy protocols or whether they can function as efficientiy as those of B cells The use of an inducible expression system such as tiie tetracycline system from Bujard and co-workers (Gossen et al, 1995) should prove to be usetal for addressing such an issue.”
A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors.
Ozawa, C. R., Springer, M. L., & Blau, H. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.295 · Cited by 41
Luger, A., Sauer, B., Lorenz, N. I., Engel, A. L., Braun, Y., Voß, M., Harter, P. N., Steinbach, J., & Ronellenfitsch, M. W. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051504 · Cited by 47
“Two principle systems with opposite responsiveness are available: Tet-on systems rely on a transactivator protein that in the absence of tetracycline/doxycycline is unable to bind to its corresponding promoter and activate transcription [1].”
Tomioka, I., Nogami, N., Nakatani, T., Owari, K., Fujita, N., Motohashi, H., Takayama, O., Takae, K., Nagai, Y., & Seki, K. (2017) · Biology of Reproduction · doi:10.1093/biolre/iox129 · Cited by 43
Campbell, L. J., Willoughby, J. J., & Jensen, A. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051270 · Cited by 36
“Lastly, the tetracycline (Tet)- or doxycycline (Dox)-inducible Tet-On system [10,11] has been used in zebrafish to conditionally control Tet-responsive transgene expression in specific cell types.”
Carette, X., Blondiaux, N., Willery, E., Hoos, S., Lecat-Guillet, N., Lens, Z., Wohlkonig, A., Wintjens, R., Soror, S., Frénois, F., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1113 · Cited by 40
Kämpf, M. M., Christen, E. H., Ehrbar, M., Baba, M. D., Hamri, G. C., Fussenegger, M., & Weber, W. (2010) · Advanced Functional Materials · doi:10.1002/adfm.200902377 · Cited by 37
Vinet, L., Rouet‐Benzineb, P., Marniquet, X., Pellegrin, N., Mangin, L., Louedec, L., Samuel, J., & Mercadier, J.-J. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01101.2007 · Cited by 43
“Transactivation of a responsive promoter placed upstream of the TG of interest by tet-off (tTA) or tet-on (rtTA) is inhibited or enhanced, respectively, by tetracycline, which prevents (tTA) (8) or permits (rtTA) (11, 35) binding to the corresponding promoter.”
BackgroundRibot, E., Bouzier-Sore, A.-K., Bouchaud, V., Miraux, S., Delville, M., Franconi, J.-M., & Voisin, P. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701060 · Cited by 40
Promoter crosstalk effects on gene expression.
Hampf, M., & Gossen, M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.009 · Cited by 40
Self-citationChiba, H., Sakai, N., Murata, M., Osanai, M., Ninomiya, T., Kojima, T., & Sawada, N. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200608012 · Cited by 37
“Cell lines and cell culture The F9 mouse embryonal carcinoma cell line F9 L32T2, which exhibits both Dox-inducible gene expression (Tet-on; Gossen et al., 1995) and tamoxifen-dependent Cre-mediated recombination (Metzger and Chambon, 2001) systems, was generated as described previously (Chiba et…”
MethodAn improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy
Sipo, I., Picó, A. H., Wang, X., Eberle, J., Petersen, I., Weger, S., Poller, W. C., & Fechner, H. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0009-1 · Cited by 36
“Most extensively studied system, which is also widely used in gene therapeutic investigations, is the Tet-regulatable system with its two variants Tet-On [6] and Tet-Off [7].”
BackgroundZhang, Q.-H., Wang, J.-R., Fan, S.-Q., Wang, L.-L., Cao, L., Tang, K., Peng, C., Li, Z., Li, W.-F., Gan, K., et al. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.058 · Cited by 40
“LRRC4 on inhibiting glioma tumorigenesis by flow cytometry and Western blot analysis using Tet on system [11,12].”
MethodKallin, A., Demoulin, J., Nishida, K., Hirano, T., Rönnstrand, L., & Heldin, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312996200 · Cited by 40
Vaysse, L., Harbottle, R., Bigger, B., Bergau, A., Tolmachov, O., & Coutelle, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311894200 · Cited by 40
Mizuguchi, H., & Hayakawa, T. (2002) · Journal of Gene Medicine · doi:10.1002/jgm.261 · Cited by 40
“The tet-off system [1], which uses the tetracycline-responsive transcriptional activator (tTA), and the tet-on system [2], which uses the reverse tetracycline-responsive transcriptional activator (rtTA), provide negative and positive control of transgene expression, respectively.”
BackgroundTransgenic study of energy homeostasis equation: implications and confounding influences
Inui, A. (2000) · The FASEB Journal · doi:10.1096/fj.00-0291rev · Cited by 38
“The regional and temporal specificity can be achieved by new genetic strategies such as Cre/lox P recombination system and a tetracycline-controlled gene induction system (149, 172, 173), which could resolve the major drawbacks of the conventional transgenic technology and allow identification of causal relationships…”
Cañete-Soler, R., Schwartz, M. L., Hua, Y., & Schlaepfer, W. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12650 · Cited by 39
Cancer Chemoprevention by Connexins
Vine, A., & Bertram, J. (2004) · Cancer Metastasis Review · doi:10.1023/a:1021250624933 · Cited by 40
“We chose to use HeLa cells, derived from a human cervical carcinoma, for the following reasons: first, an inducible system based on a bacterial receptor for tetracycline and a bacterial response element had recently been described in HeLa cells [42]; second, HeLa cells have been reported to be connexin 43 negative, wh…”
MethodMeyuhas, R., Pikarsky, E., Tavor, E., Klar, A., Abramovitch, R., Hochman, J., Lago, T. G., & Honigman, A. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2086 · Cited by 39
“Construction of Conditional Expressing CREB Stable Clones BNL1ME and Rev-2-T6 cells were transfected with the transactivator rtTA of the Tet-on system (58) and the hygromycin-resistant gene, a kind gift from H.”
MethodProgress in gene targeting: using mutant mice to study renal function and disease
Kohan, D. E. (2008) · Kidney International · doi:10.1038/ki.2008.146 · Cited by 41
Li, L.-S., Li, F.-R., Qi, H., Feng, G., Yuan, K.-H., Deng, H., & Zhou, H.-X. (2008) · Stem Cells and Development · doi:10.1089/scd.2008.0060 · Cited by 39
“After a vector that contains a gene under the control of a tet-responsive element (TRE) is transfected into a Tet-On cell line, the rtTA binds to the TRE, thus activating transcription in the presence of doxycycline (Dox) [18].”
Paepe, M. E. D., Gundavarapu, S., Tantravahi, U., Pepperell, J. R., Haley, S. A., Luks, F. I., & Mao, Q. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071123 · Cited by 31
“In the tet-on system, transgene expression is induced by binding of the tetracycline analogue, doxycycline (Dox) to rtTA, which in turn activates the (tetOp)7CMV target promoter, activating transcription of the gene of interest.(34,35) Tetracycline-dependent transgene expression was targeted to respiratory epithelial…”
BackgroundPotential applications of RNA interference technology in the treatment of cancer.
Lage, H. (2005) · Future Oncology · doi:10.1517/14796694.1.1.103 · Cited by 39
“The two most widely used inducible systems in mammalian cells use tetracyline- [39] and ecdysone-responsive [40] transcriptional elements.”
BackgroundJiang, W., Prokopenko, O., Wong, L., Inouye, M., & Mirochnitchenko, O. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.15.6496-6508.2005 · Cited by 39
“Upon transfection of HeLa-tTA cells (8) with S and As plasmids, stable”
Hossini, A., Eberle, J., Fecker, L. F., Orfanos, C., & Geilen, C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01017-2 · Cited by 39
Wilson, S. P., & Yeomans, D. C. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04516.x · Cited by 39
Aurisicchio, L., Bujard, H., Hillen, W., Cortese, R., Ciliberto, G., Monica, N. L., & Palombo, F. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301596 · Cited by 39
“In a second version, a mutated form of tTA, rtTA, binds and activates transcription only in the presence of Dox. 12 Both Tet systems were used in gene therapy models whereby a variety of vectors were applied: retroviruses, adenoassociated virus (AAV) binary systems, first generation adenoviruses, and electroporated DN…”
MethodSelf-citationvan Craenenbroeck, K., Vanhoenacker, P., Leysen, J., & Haegeman, G. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01719.x · Cited by 39
“For the construction of the luciferase (luc) expressing plasmid, pluc, the XhoI±BsrBI fragment of pUHC13-3 (Gossen et al., 1995) consisting of TRE±CMVmin±luc±polyA, was inserted into the HindIII±SalI site of p220.”
MethodInfluentialBaculovirus Insecticide Production in Insect Larvae.
van Beek, N. V., & Davis, D. C. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3043-2_20 · Cited by 39
Gene regulation technologies for gene and cell therapy
Butterfield, G. L., Reisman, S. J., Iglesias, N., & Gersbach, C. A. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.04.004 · Cited by 43
“92,93 This approach has resulted in FDA-approved treatments such as Amondys 45, Exondys 51, and Vyondys 53, which lead to the production of partially functional dystrophin protein by skipping mutated exons.”
Loss of biased signaling at a G protein-coupled receptor in overexpressed systems
Li, A., Liu, S., Huang, R., Ahn, S., & Lefkowitz, R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283477 · Cited by 38
“Such systems consist of two elements–a constitutively expressed reverse tetracycline-controlled transactivator (rtTA) and a gene of interest controlled by an rtTA-dependent tetracycline response element (TRE)–and thereby enable titration of gene expression by treatment with variable amounts of doxycycline (Fig 1A) [31…”
BackgroundStefanov, B., Teixeira, A. P., Mansouri, M., Bertschi, A., Krawczyk, K., Hamri, G. C., Xue, S., & Fussenegger, M. (2021) · Advanced Science · doi:10.1002/advs.202101813 · Cited by 43
Azizoğlu, A., Brent, R., & Rudolf, F. (2019) · bioRxiv · doi:10.7554/elife.69549 · Cited by 38
Characterization of MYC-Induced Tumorigenesis by in Situ Lipid Profiling
Perry, R. H., Bellovin, D. I., Shroff, E. H., Ismail, A. I., Zabuawala, T., Felsher, D. W., & Zare, R. N. (2013) · Analytical Chemistry · doi:10.1021/ac400479j · Cited by 40
Involvement of Dynamin-Related Protein 1 in Free Fatty Acid-Induced INS-1-Derived Cell Apoptosis
Peng, L., Men, X., Zhang, W., Wang, H., Xu, S., Fang, Q., Liu, H., Yang, W., & Lou, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049258 · Cited by 31
“The plasmid for second stable transfection was constructed by subcloning cDNA encoding rat Drp-1 or its dominantnegative mutant Drp-1 K38A into the expression vector PUHD103 [36].”
Destabilizing Domains Mediate Reversible Transgene Expression in the Brain
Tai, K., Quintino, L., Isaksson, C., Gussing, F., & Lundberg, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046269 · Cited by 38
“Moreover, mutations on the transcription factors can be created to make the systems more sensitive to induction, thereby increasing their operational window [4,10].”
Transcription regulates telomere dynamics in human cancer cells
Arora, R., Brun, C. M., & Azzalin, C. M. (2012) · RNA · doi:10.1261/rna.029587.111 · Cited by 41
“To overcome this limitation we combined the telomere-seeding phenomenon with the inducible gene expression Tet-ON technology (Barnett et al. 1993; Gossen et al. 1995) and engineered a human cell line carrying ‘‘transcriptionally inducible telomeres’’ (tiTELs).”
MethodZambon, A. C., Wilderman, A. S., Ho, A., & Insel, P. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.268979 · Cited by 33
Wübbenhorst, D., Dumler, K., Wagner, B., Wexel, G., Imhoff, A. B., Gänsbacher, B., Vogt, S., & Anton, M. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27461 · Cited by 32
Hintze, V., Steplewski, A., Ito, H., Jensen, D. A., Rodeck, U., & Fertala, A. (2008) · Human Mutation · doi:10.1002/humu.20736 · Cited by 35
“Such a baseline expression of recombinant proteins whose biosynthesis depends on a Tet-responsive promoter is expected and may be a result of residual amounts of tetracycline present in cell culture media or a marginal nonspecific activation of the Tet promoter [Gossen et al., 1995].”
BackgroundTransactivator and structurally optimized inducible lentiviral vectors.
Haack, K., Cockrell, A., Ma, H., Israeli, D., Ho, S., McCown, T., & Kafri, T. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.06.109 · Cited by 38
“Several regulatable gene expression systems have been described [2–7], among which the tetracycline-inducible systems (‘‘Tetoff’’ and ‘‘Tet-on’’) are the best characterized [8–10].”
Zhang, H.-G., Yang, P., Xie, J.-F., Liu, Z., Liu, D., Xiu, L., Zhou, T., Wang, Y., Hsu, H.-C., & Mountz, J. (2002) · Journal of Immunology · doi:10.4049/jimmunol.168.8.4164 · Cited by 38
“E-mail address: Huang-Ge.Zhang@ccc.uab.edu 2 Abbreviations used in this paper: CII, collagen II; BlyS, B lymphocyte stimulator; rtTA, reverse tetracycline transactivator; FasL, Fas ligand; TRE, tetracycline response element; TACI, transmembrane activator and calcium modulator and cyclophilin ligand interactor; sTACI,…”
BackgroundInfluentialPayen, E., Bettan, M., Henri, A., Tomkiewitcz, E., Houque, A., Kuzniak, I., Zuber, J., Scherman, D., & Beuzard, Y. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.217 · Cited by 36
“Several other interesting areas are currently under study, as follows: (i) the combination of transactivator and reporter genes in the same vector, in order to facilitate gene transfer in vivo; (ii) the association of the hypoxia regulation system with the reverse tetracyclinedependent transactivator [44], instead of…”
BackgroundSun, L.-J., Liu, Y., Frémont, M., Schwarz, S., Siegmann, M., Matthies, R., & Jost, J.-P. (1998) · Gene · doi:10.1016/s0378-1119(97)00626-4 · Cited by 38
Prometheus' myth revisited: transgenic mice as a powerful tool to study liver regeneration
Pistoi, S., & Morello, D. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.8.8666158 · Cited by 38
“A further refinement would be to obtain an inducible expression of the Crc, for instance, by putting it under the control of tetracycline (13) or interferon (14) responding sequences.”
BackgroundSerotonin Receptors: Genetic insights into serotonin function
Heath, M. J., & Hen, R. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00199-0 · Cited by 38
Light-regulated gene expression in Bacteria: Fundamentals, advances, and perspectives
Ohlendorf, R., & Möglich, A. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1029403 · Cited by 37
“The homodimeric Tet repressor (TetR) supports many applications in both prokaryotic and eukaryotic hosts, prominently so within the Tet-ON and Tet-OFF systems (Gossen et al., 1995).”
BackgroundPolstein, L. R., Juhas, M., Hanna, G., Bursac, N., & Gersbach, C. (2017) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00147 · Cited by 37
Genetically Engineered Mouse Models for Drug Development and Preclinical Trials
Lee, H. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.074 · Cited by 37
“It was fi rst developed for in vivo use in 1995 (Gossen et al., 1995), and this system has been used in many fi elds to analyze the outcomes of gene expression after the onset of disease in mice.”
MethodTetracycline-dependent expression of the human erythropoietin gene in transgenic chickens
Koo, B., Kwon, M., Lee, H., Kim, M., Kim, D., Roh, J., Park, Y.-Y., Cui, X.-S., Kim, N.-H., Byun, S., et al. (2010) · Transgenic research · doi:10.1007/s11248-009-9327-3 · Cited by 37
Chung, H., Jensen, D. A., Gawron, K., Steplewski, A., & Fertala, A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.05.004 · Cited by 37
A genetic time‐delay circuitry in mammalian cells
Weber, W., Kramer, B. P., & Fussenegger, M. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21463 · Cited by 37
“We compared expression kinetics of the tetracyclineresponsive time-delay circuitry to the conventional tetracycline-inducible TET-ON system (Gossen et al., 1995) following inducer administration.”
Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon
Geurts, A. M., Wilber, A., Carlson, C. M., Lobitz, P. D., Clark, K., Hackett, P. B., McIvor, R., & Largaespada, D. (2006) · BMC Biotechnology · doi:10.1186/1472-6750-6-30 · Cited by 37
“The activity of tTA is regulable by administering the drug tetracycline or its analog doxycycline [15].”
BackgroundRNAi Based Approaches to the Treatment of Malignant Glioma
Mathupala, S., Guthikonda, M., & Sloan, A. (2006) · Technology in Cancer Research and Treatment · doi:10.1177/153303460600500313 · Cited by 37
Weber, W., Marty, R. R., Keller, B., Rimann, M., Kramer, B. P., & Fussenegger, M. (2002) · Biotechnology and Bioengineering · doi:10.1002/bit.10461 · Cited by 37
“Both systems have been found to be functionally compatible with each other as well as with the well-established Tet systems (Fussenegger et al., 2000; Gossen and Bujard, 1992; Gossen et al., 1995).”
BackgroundKing, T. J., Fukushima, L. H., Yasui, Y., Lampe, P. D., & Bertram, J. S. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10071 · Cited by 38
“Our development of HT-1080 human fibrosarcoma cell lines containing an inducible Cx43 gene allows for the evaluation of effects of Cx43 induction both in vitro and in vivo [12,13].”
BackgroundRendahl, K. G., Quiroz, D., Ladner, M. B., Coyne, M. Y., Seltzer, J., Manning, W. C., & Escobedo, J. A. (2002) · Human Gene Therapy · doi:10.1089/10430340252769842 · Cited by 36
“The first in vivo studies incorporating the original tet-off (Gossen and Bujard, 1992) and tet-on (Gossen et al ., 1995) systems into recombinant adeno-associated viral (rAAV) vectors showed robust induction of transgene expression in muscle, and a lack of significant humoral or T cell response to…”
Li, L.-Y., Shih, H.-M., Liu, M.-Y., & Chen, J.-Y. Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103821200 · Cited by 37
Ausserlechner, M., Obexer, P., Wiegers, G. J., Hartmann, B., Geley, S., & Kofler, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008188200 · Cited by 37
Upregulation of Tyrosine Kinase TKT by the Epstein-Barr Virus Transactivator Zta
Lu, J., Chen, S.-Y., Chua, H.-H., Liu, Y.-S., Huang, Y.-T., Chang, Y., Chen, J.-Y. Y., Sheen, T., & Tsai, C.-H. (2000) · Journal of Virology · doi:10.1128/jvi.74.16.7391-7399.2000 · Cited by 37
“3 tet-on system (kindly provided by H. Bujard, University of Heidelberg, Heidelberg, Germany) (16).”
Strategies of Conditional Gene Expression in Myocardium
Heine, H. L., Leong, H. S., Rossi, F. M. V., McManus, B. M., & Podor, T. J. (2005) · Methods in molecular medicine · doi:10.1007/978-1-59259-879-3_8 · Cited by 40
Kühn, R., & Schwenk, F. (2003) · Methods in molecular biology · doi:10.1385/1-59259-340-2:159 · Cited by 37
Modelling acute myeloid leukemia (AML): What’s new? A transition from the classical to the modern
Dozzo, A., Galvin, A., Shin, J., Scalia, S., O’Driscoll, C. M., & Ryan, K. B. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01189-4 · Cited by 40
“While in the Tet-on system, the rtTA requires the presence of tetracycline or its derivatives for specific Tet-O binding and gene expression [230].”
BackgroundWang, T., & Guo, X. H. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10640-w · Cited by 42
Tissue Distribution of Doxycycline in Animal Models of Tuberculosis
Gengenbacher, M., Zimmerman, M., Sarathy, J., Kaya, F., Wang, H., Mina, M., Carter, C., Hossen, M. A., Su, H.-W., Trujillo, C., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02479-19 · Cited by 36
A possible aid in targeted insertion of large DNA elements by CRISPR/Cas in mouse zygotes
Nakao, H., Harada, T., Nakao, K., Kiyonari, H., Inoue, K., Furuta, Y., & Aiba, A. (2015) · genesis · doi:10.1002/dvg.22914 · Cited by 36
“…cargo (designated as EGFP-TRE-Cas9) containing an EGFPpolyA cassette, an hCas9 cDNA and a bidirectional promoter TRE3G which is responsive to rtTA regulatory proteins in the Tet-On system (Gossen et al., 1995) flanked by 8.1 kb 50 and 3.6 kb 30 homology arms relative to the sgRNA target site (Fig.”
BackgroundInfluentialDas, A. T., Zhou, X., Metz, S. W., Vink, M. A., & Berkhout, B. (2016) · Biotechnology Journal · doi:10.1002/biot.201500236 · Cited by 36
“Because long-term exposure to effectors is often undesirable, the Tet-On system is preferred in applications in which gene expression should be switched off for extended periods or when rapid gene induction is required [6, 7].”
BackgroundGeneration of transgenic dogs that conditionally express green fluorescent protein
Kim, M., Oh, H., Park, J., Kim, G. A., Hong, S., Jang, G., Kwon, M., Koo, B., Kim, T., Kang, S., et al. (2011) · Genesis · doi:10.1002/dvg.20737 · Cited by 36
Duerr, J., Gruner, M., Schubert, S. C., Haberkorn, U., Bujard, H., & Mall, M. A. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0115oc · Cited by 28
Self-citation
Metadata
- Authors
- Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H.
- Affiliations
- Heidelberg University (DE)
- ORCID
- Gossen, Manfred
- Venue
- Science
- Published
- 1995-06-23
- Volume
- 268
- Issue
- 5218
- Pages
- 1766-1769
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2005275397
- Cited by
- 2,488
- References
- 0
- Citations by year
- 2026: 31 · 2025: 43 · 2024: 45 · 2023: 49 · 2022: 55 · 2021: 60 · 2020: 68 · 2019: 52 · 2018: 55 · 2017: 47 · 2016: 52 · 2015: 62 · 2014: 53 · 2013: 67 · 2012: 64
- FWCI
- 48.56
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- tetracycline, transcriptional activation, Tet repressor, VP16 activation domain, doxycycline, gene expression regulation, transcriptional activator, transgenic animals, gene therapy
- MeSH terms
- Amino Acid Sequence, Doxycycline, HeLa Cells, Humans, Molecular Sequence Data, Operator Regions, Genetic, Recombinant Fusion Proteins, Repressor Proteins, Transfection, Viral Proteins, Transcriptional Activation, Trans-Activators, Genes, Reporter, Simplexvirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review